Replies to post #91587 on Mohacsy's Safe Portfolio Member Forum

[morokoy]

I'll also hunker down and wait to see if a DNA vaccine gets approved, as opposed to the mRNA's around. While the daunting task of vaccinating 300M+ folks goes on, there will be millions who get sick and need hospitalization, which is why I think the real money is to be made from the therapeutic sector - Inovio INO, Humanigen HGEN, Cytodyn CYDY, Relief RLFTF, Revive RVVTF, Biocryst BCRX.
BCRX interests me, since I tend to follow the Baker Brothers, who did well this month with ALXN, kind of making up for the drubbing they took on AMRN (which I am now selling off for tax purposes).